Aprogen Pharmaceuticals Inc Income Statement

3060 KRW1090 -15.0 -1.4%

05/03/21

Highly Speculative, Small Cap, Falling Star

Market Cap £276.5m

Enterprise Value £184.6m

Revenue £35.3m

Quality

Value

Momentum

StockRank™

To unlock Aprogen Pharmaceuticals Inc's income statement please upgrade your membership.

	2014	2015	2016	2017	2018	2019
Period End:	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31
Period Length:	12M	12M	12M	12M	12M	12M
Currency:	KRW	KRW	KRW	KRW	KRW	KRW

Revenue
Total Revenue

Cost of Revenue, Total
Gross Profit

Selling/General/Administrative Expenses, Total
Research & Development
Depreciation/Amortization
Unusual Expense (Income)

Total Operating Expense
Operating Profit/Income

Gain (Loss) on Sale of Assets
Total Non Operating Interest Expense
Other, Net
Income Before Tax
Income Tax - Total
Income After Tax

Minority Interest
Net Income Before Extra. Items
Net Income

Income Available to Common Excl. Extra. Items
Income Available to Common Incl. Extra. Items
Dilution Adjustment
Diluted Net Income
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Incl. Extraordinary Items
Diluted EPS Excluding Extraordinary Items

Normalized Income Before Taxes
Normalized Income After Taxes
Normalized Inome Avail to Common Stock
Diluted Normalized EPS

Dividends per Share - Common Stock Primary Issue

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.